Pain Therapeutics — SMi’s 22nd Annual Pain Therapeutics Conference

SMi’s 22nd Pain Therapeutics Conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the latest advancements in the field, highlighting the use of opioids and the future for cannabinoids within the pain therapeutics field. Furthermore, policy experts will provide an essential regulatory perspective for this year’s agenda, providing an exciting and comprehensive insight into the pain therapeutics market.

Topics: Pain therapeutics, Analgesic, neuropathic pain, chronic pain, peripheral sensitization, NGF, Post-operative pain, osteoarthritis, pain, pain therapeutics, opioids, Nerve Growth Factor, neuroscience, opioid crisis, opioid epidemic, biomarkers, molecular targets, clinical models, osteoarthritis, neuropathic pain, headache pain, neuroscience, neurotrophin, neuro-immune interactions